Wedge Industrial Co.,Ltd. (SHE:000534)

Market Cap	8.32B +6.0%
Revenue (ttm)	1.29B +4.1%
Net Income	171.03M -23.6%
EPS	0.34 -23.7%
Shares Out	482.35M
PE Ratio	51.29
Forward PE	30.30
Dividend	0.05 (0.29%)
Ex-Dividend Date	Aug 14, 2025

Volume	17,638,720
Open	16.97
Previous Close	16.97
Day's Range	16.50 - 17.45
52-Week Range	15.95 - 49.14
Beta	0.44
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About Wedge Industrial

Wedge Industrial Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China. It offers microecological preparations, such as bifidobacterium lactobacillus triple live bacteria tablets under the Golden Bifidobacterium brand; vaginal lactobacillus live capsules under the Dingjun Sheng brand; dual-span microecological live bacteria drugs under the Jin Shuangqi brand; and vaginal microecological live bacteria drug for ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 1,438
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000534

Financial Performance

In 2025, Wedge Industrial's revenue was 1.29 billion, an increase of 19.62% compared to the previous year's 1.08 billion. Earnings were 197.02 million, an increase of 2.22%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 28, 2026

Data Sources Report a data error